Specifications include, but are not limited to: The purpose of this ITB is to solicit interest and bids among Idaho universities to conduct comprehensive evaluations on two (2) previously developed media campaigns, which will aim to assess campaign reach and effectiveness. The Department’s Drug Overdose Prevention Program (DOPP) aims to reduce overdose numbers and promote opioid use disorder treatment within the state. In 2022, DOPP developed two (2) media campaigns to raise awareness on the risks of illicitly manufactured fentanyl and to reduce healthcare provider stigma associated with patients with substance use disorder. The first campaign, a fentanyl awareness campaign, utilizes Centers for Disease Control and Prevention (CDC) marketing materials to communicate the high risk of fatal overdose when ingesting street drugs due to the increased presence of fentanyl within Idaho’s illicit drug supply. The campaign aims to target people who use drugs, especially recreational drug users, as well as their families and friends. Fentanyl awareness campaign materials were disseminated through social media, digital display and video, paid search, and out-of-home advertising via posters and jukebox ads in bars. The campaign dissemination occurred from June 2022-August 2022. The second campaign, a provider stigma reduction campaign, aims to reduce stigma among two (2) patient populations: Patients with substance use disorder and pregnant patients who use drugs. The campaign utilized in-depth interviews with Idaho healthcare providers and recovery coaches to assist in the creative development process and to contribute to intended message. . The campaign’s priority populations are providers at community health centers (CHCs) (also known as federally qualified health centers) and tribal health clinics in Idaho. The anticipated timeline for campaign dissemination is February 2023-April 2023.
